1. Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2− subtype breast cancer
   Lei Liu et al, 2017, Scientific Reports CrossRef
2. Transcriptome analysis of long noncoding RNAs reveals their potential roles in anthracycline-induced cardiotoxicity
   Nhan Nguyen et al, 2022, Non-coding RNA Research CrossRef
3. Profiling of specific long non‐coding RNA signatures identifies ST8SIA6‐AS1 AS a novel target for breast cancer
   Zhanghan Chen et al, 2021, The Journal of Gene Medicine CrossRef
4. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
   Hai-Bo Zhang et al, 2023, Frontiers in Pharmacology CrossRef
5. Research Progress on the Effect of lncRNA on Chemoresistance of Breast Cancer
   瀚林 杜, 2024, Advances in Clinical Medicine CrossRef
6. Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
   Huijun Zeng et al, 2017, International Journal of Oncology CrossRef
7. Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer
   Elena-Georgiana Dobre et al, 2020, Cancers CrossRef
8. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27Kip1
   Gang Luo et al, 2017, Molecular Cancer Research CrossRef
9. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
   Duncan Ayers et al, 2017, Genes CrossRef
10. Integrative Analysis of the Doxorubicin-Associated LncRNA–mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression
    Qi Chen et al, 2020, Frontiers in Genetics CrossRef
11. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
    Alma D. Campos-Parra et al, 2018, International Journal of Molecular Sciences CrossRef